navigation
Deutsch English Home Service Bitte wählen Sie Bitte wählen Sie Bitte wählen Sie Bitte wählen Sie Bitte wählen Sie Bitte wählen Sie Bitte wählen Sie

   Fachinformationen
   Patienteninformationen
   Qualitätsmanagement
   Forschung
   Web-Adressen  

nav_footer
nav_dekoline
Home → Service → Forschung → Expression and inducibility of drug-metabolizing enzymes in preneoplastic and neoplastic lesions of rat liver during nitrosamine-induced hepatocarcinogenesis


Expression and inducibility of drug-metabolizing enzymes in preneoplastic and neoplastic lesions of rat liver during nitrosamine-induced hepatocarcinogenesis

H. W. Kunz, A. Buchmann, M. Schwarz, R. Schmitt, Wolf D. Kuhlmann,
C. R. Wolf, F Oesch

Institute of Biochemistry, German Cancer Research Centre, D-6900 Heidelberg, FRG
Imperial Cancer Research Fund, Laboratory of Molecular Pharmacology and Drug Metabolism,
University Department of Biochemistry, Edinburgh, UK
Institute of Toxicology, University of Mainz, D-6500 Mainz, FRG



The expression, inducibility, and regulation of four different cytochrome (cyt.) P-450 isoenzymes (PB1, PB2, MC1, and MC2), NADPH-cytochrome P-450 reductase, the glutathione transferases (GSTs) B and C and microsomal epoxide hydrolase (mEHb) have been studied during nitrosamine-induced hepatocarcinogenesis using immunohistochemical techniques (immunoperoxidase method). The investigations revealed basic differences in the expression of the individual drug metabolizing enzymes in the course of neoplastic development.

download